A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf.
A radiopaque polymer hydrogel used as a fiducial marker in gynecologic-cancer patients receiving brachytherapy
2015
Preserved Fulltext
We assessed a novel Food and Drug Administration–approved hydrogel, synthesized as absorbable iodinated particles, in gynecologic-cancer patients undergoing computed tomography (CT) or magnetic resonance (MR) based brachytherapy after external beam radiation.
doi:10.17615/t9sb-tg26
fatcat:ynpfzsqltbdmrheiiijgav4zmq